Purpose of Service
Our strategy
Current locations：：Home > Our strategy
Through innovative research and development of high-quality drugs to serve patients, we focus our technology and resources on a series of priority products and platforms, and achieve a leading position in the field of research and development: the latest dosage form of external medicine ----gel; At the same time, we also pay close attention to the cooperation and opportunities in the field of extracorporeal use of human genes, such as ent, rub and enema.
Due to climate change, environmental pollution and other factors, dermatology and ent drugs account for the following:
30.57% in China
36.5% In west Africa
20.5% in southeast Asia
19.54% in Latin America
18.3% In Europe
21% in Asia
Due to climate change, environmental pollution and other factors, dermatology and ent drugs account for the following:
30.57% in China
36.5% In west Africa
20.5% in southeast Asia
19.54% in Latin America
18.3% In Europe
21% in Asia